$263.99
0.470.18%
마지막 업데이트: Sep 14, 2:22 PM
Benzinga
Benzinga
Benzinga
월요일, 9월 14
Ascendis Pharma AS
ASNDNASDAQ
Ascendis Pharma Earnings & Forecasts
Ascendis Pharma (ASND) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Ascendis Pharma Guidance
Ascendis Pharma (ASND)는 1월 9, 2026에 fiscal year 2025에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $838.19M - $838.19M 범위로 예상했습니다.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.78 | $0.21 | $-0.06 | $-0.41 |
| Actual | $1.05 | $0.32 | $-0.64 | $-1.17 |
| Surprise | +34.6% | +52.4% | -966.7% | -185.1% |
| Revenue | ||||
| Estimate | $353.8M | $318.1M | $289.7M | $248.6M |
| Actual | $394.4M | $288.8M | $288.1M | $249.8M |
| Surprise | +11.5% | -9.21% | -0.55% | +0.46% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.13 | $1.42 | $1.49 | $2.05 |
| Revenue | ||||
| Consensus | $420.1M | $466.6M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved